Other languages Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
32.41 ^USD	-8.91%		-13.55%	+50.60%

Apr. 19	Sector Update: Health Care Stocks Steady Pre-Bell Friday	MT
Apr. 19	Spyre Therapeutics Files Mixed-Securities Shelf Registration for About 33.4 Million Shares	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Spyre Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29
Spyre Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Spyre Therapeutics, Inc. Announces Board Changes	Feb. 05
Spyre Therapeutics Agrees to Sell Shares in Private Placement for Expected Gross Proceeds of About $180 Million	Dec. 08
Aeglea BioTherapeutics, Inc. will Change its Ticker to SYRE from AGLE	Nov. 28
Aeglea BioTherapeutics Changes Name to Spyre Therapeutics; CEO Appointed	Nov. 27
Aeglea BioTherapeutics, Inc. Appoints Cameron Turtle as Chief Executive Officer	Nov. 27
Aeglea BioTherapeutics, Inc. Announces Executive Changes	Nov. 27
Aeglea BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Aeglea BioTherapeutics, Inc. Announces Appointment of Cameron Turtle as Principal Executive Officer	23-10-10
Aeglea BioTherapeutics Appoints Scott Burrows as CFO	23-09-05
Aeglea BioTherapeutics, Inc. Announces Executive Changes	23-09-05
Aeglea BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11
Aeglea BioTherapeutics Sells Rights to Investigational Metabolic Disease Treatment to Immedica Pharma; Shares Rise Pre-Bell	23-07-27
Aeglea BioTherapeutics, Inc. Enters into Agreement with Immedica Pharma AB	23-07-27
Immedica Pharma acquired global rights to pegzilarginase from Aeglea BioTherapeutics, Inc. for approximately $120 million.	23-07-26
Sector Update: Health Care Stocks Climb Thursday	23-06-22
Sector Update: Health Care	23-06-22
Top Midday Gainers	23-06-22
Aeglea BioTherapeutics Acquires Spyre Therapeutics; Shares Surge Pre-Bell	23-06-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Other languages

Filters